GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Price-to-Owner-Earnings

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Price-to-Owner-Earnings : 10.91 (As of Dec. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Price-to-Owner-Earnings?

As of today (2024-12-15), Laboratorio Farmaceutico Erfo SpA's share price is €1.20. Laboratorio Farmaceutico Erfo SpA's Owner Earnings per Share (TTM) ended in Dec. 2023 was €0.11. It's Price-to-Owner-Earnings for today is 10.91.


The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings or its related term are showing as below:

FRA:RK7' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.87   Med: 11.92   Max: 13.19
Current: 10.53

During the past 5 years, the highest Price-to-Owner-Earnings of Laboratorio Farmaceutico Erfo SpA was 13.19. The lowest was 9.87. And the median was 11.92.


FRA:RK7's Price-to-Owner-Earnings is ranked better than
62.65% of 905 companies
in the Consumer Packaged Goods industry
Industry Median: 14.74 vs FRA:RK7: 10.53

As of today (2024-12-15), Laboratorio Farmaceutico Erfo SpA's share price is €1.20. Laboratorio Farmaceutico Erfo SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.05. Therefore, Laboratorio Farmaceutico Erfo SpA's PE Ratio (TTM) for today is 25.53.

As of today (2024-12-15), Laboratorio Farmaceutico Erfo SpA's share price is €1.20. Laboratorio Farmaceutico Erfo SpA's EPS without NRI for the trailing twelve months (TTM) ended in was €0.05. Therefore, Laboratorio Farmaceutico Erfo SpA's PE Ratio without NRI for today is 22.64.

During the past 5 years, Laboratorio Farmaceutico Erfo SpA's highest PE Ratio without NRI was 22.79. The lowest was 9.56. And the median was 14.24.


Laboratorio Farmaceutico Erfo SpA Price-to-Owner-Earnings Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Price-to-Owner-Earnings Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - 14.75

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - 14.75 -

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings falls into.



Laboratorio Farmaceutico Erfo SpA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.20/0.11
=10.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA  (FRA:RK7) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Laboratorio Farmaceutico Erfo SpA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Farmaceutico Erfo SpA Business Description

Traded in Other Exchanges
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in the formulation and production of food supplements, and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines